NCT05620433 (JOINTEFFORT) is a NA clinical trial of Joint Effort in Cannabis Use, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).

Who is sponsoring NCT05620433?

NCT05620433 is sponsored by Centre hospitalier de l'Université de Montréal (CHUM).

What drugs are being tested in NCT05620433?

Interventions in NCT05620433: Joint Effort, Brief normative feedback and standard information.

What condition does NCT05620433 study?

NCT05620433 studies Cannabis Use, Cannabis, Cannabis Dependence, Cannabis Smoking, Cannabis Use, Unspecified.

Is NCT05620433 still recruiting?

NCT05620433 is currently completed. Last updated 12 March 2025.

Last reviewed 2025-03-12 · How we verify

NCT05620433: JOINTEFFORT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Joint Effort 2.0: a Mobile Application With University Students

Completed NA Last updated 12 March 2025

What this trial tests

NA trial testing Joint Effort in Cannabis Use in 354 participants. Completed in 28 November 2024.

Timeline

8 February 2023

Primary endpoint
28 November 2024

28 November 2024

Quick facts

Lead sponsor	Centre hospitalier de l'Université de Montréal (CHUM)
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	354
Start date	8 February 2023
Primary completion	28 November 2024
Estimated completion	28 November 2024
Sites	1 location across Canada

Drugs / interventions tested

Joint Effort
Brief normative feedback and standard information

Conditions studied

Cannabis Use — all drugs for Cannabis Use →
Cannabis — all drugs for Cannabis →
Cannabis Dependence — all drugs for Cannabis Dependence →
Cannabis Smoking — all drugs for Cannabis Smoking →

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Who can join

Adults 18 to 35, any sex, with Cannabis Use or Cannabis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate quantitatively and qualitatively a mobile application, Joint Effort, targeting safe cannabis use among consumers. This randomized controlled trial is currently conducted on the Joint Effort mobile application.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Acceptability, Feasibility, and Outcome Responsiveness of the Joint Effort Mobile App for Promoting Lower-Risk Cannabis Use Among Young Adults: Pilot Randomized Controlled Trial.
Côté J, Chicoine G, Auger P, Vinette B, et al · · 2026 · PMID 42208065 · DOI 10.2196/71957

Verify or expand the search:

Other trials of Joint Effort

Trials testing the same drug.

NCT05099016 — Joint Effort Study · NA · completed

Other recruiting trials for Cannabis Use

Currently open trials in the same condition.

NCT07196462 — Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia · NA · recruiting
NCT07168707 — Culturally Adapted EAET-H for Chronic Pain Patients Using Medical Cannabis in Israel - A Pilot Study · NA · recruiting
NCT05999383 — Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration · Phase 2 · recruiting
NCT06883162 — Cannabis-Tobacco Co-Use Treatment Study · Phase 3 · recruiting
NCT06699251 — Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat) · NA · recruiting

Other Centre hospitalier de l'Université de Montréal (CHUM) trials

Trials by the same sponsor.

NCT06735638 — Outside the Cage (OTC) Robotic Esophagectomy · Phase 1 · not yet recruiting
NCT07533253 — Rescue Distal Thrombectomy in Treatment for Persistent Distal Occlusions · NA · not yet recruiting
NCT05225272 — Effectiveness of an Enhanced Recovery After Surgery Protocol in Patients Undergoing On-pump Cardiac Surgery · not yet recruiting
NCT07497061 — Comparison of Two Surgical Techniques for the Treatment of Trigger Fingers: Longitudinal Opening Versus Complete A1 Pull · NA · not yet recruiting
NCT07196410 — KAN-004 for Immune-Related Diarrhea or Colitis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05620433 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre hospitalier de l'Université de Montréal (CHUM)
Last refreshed: 12 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05620433.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing